======= PI4K2B =======
== Gene Information ==
* **Official Symbol**: PI4K2B
* **Official Name**: phosphatidylinositol 4-kinase type 2 beta
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55300|55300]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8TCG2|Q8TCG2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PI4K2B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PI4K2B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/612101|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the type II PI4 kinase protein family. The encoded protein is primarily cytosolic and contributes to overall PI4-kinase activity along with other protein family members. This protein is involved in early T cell activation. [provided by RefSeq, Dec 2016].
* **UniProt Summary**: Together with PI4K2A and the type III PI4Ks (PIK4CA and PIK4CB) it contributes to the overall PI4-kinase activity of the cell. This contribution may be especially significant in plasma membrane, endosomal and Golgi compartments. The phosphorylation of phosphatidylinositol (PI) to PI4P is the first committed step in the generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second messenger inositol 1,4,5-trisphosphate (InsP3). Contributes to the production of InsP3 in stimulated cells and is likely to be involved in the regulation of vesicular trafficking. {ECO:0000269|PubMed:11923287}.
|PI3 PI4 kinase|
|1-phosphatidylinositol 4-kinase activity|
|phosphatidylinositol phosphorylation|
|lipid phosphorylation|
|endosome organization|
|phosphatidylinositol biosynthetic process|
|Golgi organization|
|phosphatidylinositol metabolic process|
|trans-Golgi network|
|lipid modification|
|glycerophospholipid biosynthetic process|
|glycerolipid biosynthetic process|
|phospholipid biosynthetic process|
|endosome|
|vesicle organization|
|glycerophospholipid metabolic process|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|endomembrane system organization|
|organophosphate biosynthetic process|
|lipid biosynthetic process|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|lipid metabolic process|
|phosphorylation|
|ATP binding|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.12|
|[[:results:exp480|ETC-159 50μM R08 exp480]]|1.7|
|[[:results:exp79|Q15 2.7μM R02 exp79]]|2.79|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18560
* **Expression level (log2 read counts)**: 5.37
{{:chemogenomics:nalm6 dist.png?nolink |}}